SMTL ID : 1veb.1

Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

hetero-1-1-mer

Ligands

1 x I05: (3R,4R)-N-{4-[4-(2-FLUORO-6-HYDROXY-3-METHOXY-BENZOYL)-BENZYLOXY]-AZEPAN-3-YL}-ISONICOTINAMIDE(Non-covalent)

I05.1: 25 residues within 4Å: Chain A: G.50, T.51, G.52, S.53, F.54, G.55, R.56, V.57, A.70, K.72, L.74, Q.84, E.91, M.120, E.121, Y.122, V.123, E.127, E.170, N.171, L.173, T.183, D.184, G.186, F.327 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.54, A:L.74, A:L.173, A:T.183 Hydrogen bonds: A:F.54, A:K.72, A:E.91, A:V.123, A:N.171, A:T.183 Halogen bonds: A:S.53

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Breitenlechner, C.B. et al., Structure-based optimization of novel azepane derivatives as PKB inhibitors. J.Med.Chem. (2004)

Release Date

2005-03-29

Peptides

cAMP-dependent protein kinase, alpha-catalytic subunit: A
cAMP-dependent protein kinase inhibitor, alpha form: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

cAMP-dependent protein kinase, alpha-catalytic subunit

cAMP-dependent protein kinase inhibitor, alpha form

Related Entries With Identical Sequence